Skip to content

GKM Gesellschaft für Therapieforschung mbH

Request correction

Corporate brand

Unclaimed

German full-service contract research organization (CRO) providing clinical research services for drugs and medical devices since 1981.

Last updated September 26, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

GKM Gesellschaft für Therapieforschung mbH is a German contract research organization (CRO) headquartered in Munich. The company describes itself as a full-service CRO in Germany for clinical research involving medicinal products and medical devices. It supports international and national clinical trials as well as non-interventional studies. GKM's service portfolio covers the full lifecycle of clinical research projects. According to its official website, these services include conception and design development, medical advising and medical writing, project management, regulatory affairs, quality assurance, monitoring, data management, biostatistics, pharmacovigilance (Vigilanz), medical devices, and benefit assessment under § 35a SGB V (the German social code provision for early benefit assessment of pharmaceuticals). The company states that it has stood for flexibility, continuity, and quality in the planning, management, and conduct of clinical trials and non-interventional studies since 1981. This makes GKM one of the longer-established independent CROs in the German market. As a modern CRO, GKM emphasizes professional competence, experience, flexibility, and creativity in day-to-day work, and it actively recruits staff for careers in clinical research. The company is privately held and operates primarily in Germany while also serving international clients. GKM is based in Munich, Germany, and its official website is gkm-therapieforschung.de.

History

GKM Gesellschaft für Therapieforschung mbH was founded in 1981 and is headquartered in Munich, Germany. The company has operated as a contract research organization (CRO) for several decades, providing clinical research services for medicinal products and medical devices. From its beginnings, GKM positioned itself as a full-service CRO serving both national and international clients. Its service range grew to cover the entire clinical research process, from conception and design development through medical advising and medical writing, project management, regulatory affairs, quality assurance, monitoring, data management, biostatistics, and pharmacovigilance. The company also expanded into services for medical devices and into benefit assessment under § 35a SGB V, reflecting the evolving regulatory landscape in Germany. GKM states that it has stood for flexibility, continuity, and quality in the planning, management, and conduct of clinical trials and non-interventional studies since 1981. As a modern CRO, it emphasizes professional competence, experience, flexibility, and creativity, and it recruits staff for careers in clinical research. The company remains privately held and continues to operate from Munich, serving clients in Germany and internationally.

  • 1981

    GKM Gesellschaft für Therapieforschung mbH founded; begins providing clinical research services.

Products and positioning

Full-service CRO in Germany emphasizing flexibility, continuity, and quality since 1981.

  • Clinical trial conception and design development

    Support for designing and planning clinical trials.

  • Medical advising and medical writing

    Medical advisory services and writing of clinical documents.

  • Project management

    Management of clinical trial projects.

  • Regulatory

    Regulatory affairs support for clinical research.

  • Quality assurance

    Quality assurance services for clinical trials.

  • Monitoring

    Clinical site monitoring.

  • Data management

    Clinical data management services.

  • Biostatistics

    Biostatistical analysis for clinical trials.

  • Vigilanz (pharmacovigilance)

    Pharmacovigilance and safety monitoring.

  • Medical devices

    Clinical research services for medical devices.

  • Benefit assessment under § 35a SGB V

    Support for early benefit assessment of pharmaceuticals in Germany.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/gkm-gesellschaft-für-therapieforschung-mbh-germany · Editorial policy · How profiles are compiled